Abstract | OBJECTIVE: DESIGN: Randomized single-blinded study. PATIENTS: Eighteen patients with moderate-severe hirsutism were recruited for the study. INTERVENTIONS: RESULTS: After 6 and 9 months of treatment, the hirsutism score improved significantly in the patients receiving finasteride, whereas no significant modifications were observed in patients treated with placebo. The side effects observed were headache and depression of modest entity during the 1st month of treatments, whereas libido did not change. Serum levels of LH, FSH, androstenedione, unbound T, DHEAS, E2, 17 alpha-hydroxyprogesterone, and SHBG did not change during therapy. Hirsute patients treated with finasteride exhibited a marked decrease of dihydrotestosterone and a significant increase of T serum levels from the 3rd and 6th months of treatment, respectively. CONCLUSION:
Finasteride decreased the hirsutism score of patients affected by idiopathic hirsutism with few side effects during treatment. No modification of libido was observed.
|
Authors | L Ciotta, A Cianci, A E Calogero, M A Palumbo, E Marletta, A Sciuto, G Palumbo |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 64
Issue 2
Pg. 299-306
(Aug 1995)
ISSN: 0015-0282 [Print] United States |
PMID | 7615107
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- 5-alpha Reductase Inhibitors
- Dihydrotestosterone
- Testosterone
- Finasteride
- Luteinizing Hormone
- Follicle Stimulating Hormone
|
Topics |
- 5-alpha Reductase Inhibitors
- Adult
- Analysis of Variance
- Dihydrotestosterone
(blood)
- Female
- Finasteride
(therapeutic use)
- Follicle Stimulating Hormone
(blood)
- Hirsutism
(blood, drug therapy)
- Humans
- Luteinizing Hormone
(blood)
- Single-Blind Method
- Testosterone
(blood)
|